Drugs / RetinoStat
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01678872 | Aug 2012 → Mar 2029 expected | age-related macular degeneration | Oxford BioMedica | Active not recruiting | No outcome recorded |
| Phase 1 | NCT01301443 | Feb 2011 → Sep 2014 | wet macular degeneration | Oxford BioMedica | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RetinoStat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01678872 ↗ |
| Route | Other | “the study eye received a subretinal injection” PMID 27710144 ↗ Sep 2016 |